B cell development is critically dependent on NFATc1 activity by Giampaolo, S et al.
ARTICLE OPEN
B cell development is critically dependent on NFATc1 activity
Sabrina Giampaolo1, Gabriela Wójcik2, Stefan Klein-Hessling1,3, Edgar Serfling1,3 and Amiya K. Patra2
B cell development in bone marrow is a precisely regulated complex process. Through successive stages of differentiation, which
are regulated by a multitude of signaling pathways and an array of lineage-specific transcription factors, the common lymphoid
progenitors ultimately give rise to mature B cells. Similar to early thymocyte development in the thymus, early B cell development
in bone marrow is critically dependent on IL-7 signaling. During this IL-7-dependent stage of differentiation, several transcription
factors, such as E2A, EBF1, and Pax5, among others, play indispensable roles in B lineage specification and maintenance. Although
recent studies have implicated several other transcription factors in B cell development, the role of NFATc1 in early B cell
developmental stages is not known. Here, using multiple gene-manipulated mouse models and applying various experimental
methods, we show that NFATc1 activity is vital for early B cell differentiation. Lack of NFATc1 activity in pro-B cells suppresses EBF1
expression, impairs immunoglobulin gene rearrangement, and thereby preBCR formation, resulting in defective B cell development.
Overall, deficiency in NFATc1 activity arrested the pro-B cell transition to the pre-B cell stage, leading to severe B cell lymphopenia.
Our findings suggest that, along with other transcription factors, NFATc1 is a critical component of the signaling mechanism that
facilitates early B cell differentiation.
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INTRODUCTION
B cell development in bone marrow (BM) follows a series of
differentiation stages through which hematopoietic stem cell
(HSC)-derived common lymphoid progenitor (CLP) cells give rise
to mature B lymphocytes. Similar to early T cell development in
the thymus, early B cell development in BM is also critically
dependent on interleukin-7 (IL-7) signaling.1–5 Upon IL-7 signaling,
CLP-derived B220+CD43+ pro-B cells differentiate into
B220+CD43− pre-B cells, which subsequently differentiate into
B220+IgM+IgD− immature B cells to finally give rise to
B220+IgM+IgD+ mature B cells. Pro-B cells can also be character-
ized as B220+IL-7R+ because they respond to IL-7 signals or
B220+CD19+IgM−c-Kit+ cells because they express stem cell
factor receptor (c-Kit). Similarly, pre-B cells are otherwise
characterized as B220+IL-7R− because these cells are independent
of IL-7 signaling or B220+CD19+IgM−CD25+ because they express
the IL-2 receptor alpha chain (CD25). During the pro- to pre-B cell
transition, developing B cells rearrange their immunoglobulin (Ig)
heavy and light chains, which are essential for the formation of the
pre-B cell receptor (pBCR). PreBCR signaling imparts indepen-
dence from IL-7 signaling and is critical for further differentiation
to later developmental stages.6,7
Apart from IL-7 signaling, a host of lineage-specific transcription
factors (TF) have been implicated in the regulation of early B cell
differentiation in BM. Prominent among these TFs are the ets-
family TF PU.1, Ikaros, zinc finger TF Bcl11a, helix-loop-helix TF
E2A, EBF1 (early B cell factor 1), and paired box TF Pax5.8,9 Both
E2A and EBF1 have been reported to regulate B lineage
specification and commitment, and Pax5 activity is vital for B
lineage maintenance.10–15 Genetic ablation of these TFs has
revealed serious abnormalities in B cell development, leading to
severe B cell lymphopenia.9
EBF1 activity has been suggested to influence several aspects of
early B cell differentiation.16,17 EBF1 activity has been shown to
regulate Pax5, Pou2af1 (BOB-1/OBF1), and Foxo1 activity during
B cell development.15,18–21 The master regulatory function of EBF1 in
B lineage specification and commitment was evident from the
analysis of Ebf1−/− mice, in which development was blocked at the
pro-B cell stage.12 EBF1 in association with E2A, Runx1, and other TFs
regulates a number of B lineage-specifying genes that are involved
in early B cell survival, proliferation, and Ig gene locus accessibility
and rearrangement.16,22,23 Although the functional aspects of EBF1
in B cell development have been extensively studied, the
mechanism that induces Ebf1 expression is less well understood.
IL-7 signaling has been shown to regulate Ebf1 expression in pro-B
cells.24 Additionally, E2A and FOXO1 appear to regulate Ebf1
expression.25–27 However, a clear picture of the regulation of Ebf1
during early B cell development has yet to emerge.
Nuclear factor of activated T cell (NFAT) family TFs play
important roles in the development and function of many
hematopoietic cell lineages.28–30 Among five family members
(NFATc1, NFATc2, NFATc3, NFATc4, and NFAT5), NFATc1, NFATc2,
and NFATc3 are predominantly active in lymphocytes, where they
regulate processes as diverse as cell survival, proliferation,
cytokine gene expression, various T helper cell differentiation,
apoptosis, and immune effector function.31,32 In T or B cells, cell
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surface T cell receptor (TCR) or BCR ligation induces increased
calcium (Ca2+) flux in the cytoplasm, which requires phospholi-
pase Cγ2 (PLCγ2) activity. Increased Ca2+ subsequently activates
the serine/threonine phosphatase calcineurin, which by depho-
sphorylating multiple serine residues in cytoplasmic NFAT proteins
facilitates their activation and nuclear translocation. We have
recently described an alternative mechanism of NFAT activation in
pTCR-negative thymocytes, wherein IL-7-JAK3 activity activates
NFATc1 in a tyrosine phosphorylation-dependent manner.33 NFAT
activity in pTCR-negative thymocytes is not only critical for their
survival and differentiation into T cells but is also indispensable in
preventing the pathogenesis of T acute lymphoblastic leukemia.34
Furthermore, we and others have previously reported the
involvement of NFAT proteins in B cell development and
functions.35–38 Although NFAT proteins regulate multiple events
in B cell function, their role in early stages of B cell differentiation
in BM has not yet been investigated. Here we show that NFAT is
active in pBCR-negative B cells and that NFATc1 plays an
indispensable and non-redundant role very early during B cell
differentiation. The serious defects in early B cell differentiation in
mice lacking NFATc1 activity in the hematopoietic system led to
severe B cell lymphopenia, which further underscores the critical
necessityof NFATc1 in facilitating B cell development.
MATERIALS AND METHODS
Mice
C57BL/6 wild-type (WT), Rag1−/−, Nfatc2−/−, Nfatc3−/−,
Nfatc2−/−Nfatc3−/−, Nfatc1-eGfp-Bac tg, Vav-CreNfatc1fl/+,
Vav-CreNfatc1fl/fl, Il7−/−, Il7r−/−, Vav-CreNfatc1P2fl/fl, Vav-CreN-
fatc1αAfl/+, and Vav-CreNfatc1αAfl/fl mice, all in the C57BL/6
background and of 3–8 weeks age unless mentioned other-
wise, were used in the study. All animals were housed in the
University of Würzburg central animal facility (ZEMM) following
standard animal care procedures. All animals had ad libitum
access to food and water. In each experiment, age-matched
mice were used without any gender bias, and animals were
handled humanely throughout the study.
Flow cytometry and cell sorting
All antibodies (Abs) used in flow cytometry and for isolation of
B220+CD43+ or B220+IL-7R+ pro-B and B220+CD43− or B220+IL-
7R− pre-B cells from BM were purchased either from BD
Pharmingen or eBioscience. Anti-B220 (RA3−6BU), anti-CD43
(S7), anti-CD25 (PC61), anti-CD127 (B12-1), anti-CD3 (145-2C11),
anti-IgM (R6-60.2), anti-IgD (11-26c), anti-CD21 (7G6), anti-CD23
(B3B4), anti-CD5 (53–7.3), anti-CD19 (1D3), anti-CD117 (2B8), anti-
BP1 (6C3), anti-CD24 (M1/69), and isotype-matched control Abs
either directly conjugated to fluorochromes or to biotin were used
throughout the study. Biotinylated Abs were revealed with
secondary streptavidin-conjugated allophycocyanin or
phycoerythrin-Cy5 (PE-Cy5) Abs. Flow cytometry and data analysis
were performed following standard procedures using the
FACSCalibur and FlowJo software.
For BM pro- and pre-B cell sorting, a single-cell suspension of
BM cells from both hind limbs was prepared. WT BM cells were
either stained with B220 and CD43 or with B220 and IL-7R Abs to
sort B220+CD43+ or B220+IL-7R+ pro-B and B220+CD43− or
B220+IL-7R− pre B cells. Similarly, B220+CD43+ pro-B and
B220+CD43− pre-B cells were sorted from Rag1−/− mice BM. Cell
sorting was performed using a FACSAria (BD Biosciences) flow
cytometer and FACS DIVA software.
Immunofluorescence staining and immunoblotting
Sorted BM B220+CD43+ pro-B and B220+CD43− pre-B cells from
WT or Rag1−/− mice or B220+IL-7R+ pro-B and B220+IL-7R−pre-B
cells from WT mice were immunostained with NFATc1, NFATc2
(both from ImmunoGlobe), or NFATc3 (Santa Cruz) Abs following a
previously published protocol.39 Counterstaining with 4,6-diami-
dino-2-phenylindole was performed to confirm nuclear staining.
Image acquisition and data analysis were performed using a TCS
SP2 Leica confocal microscope and software.
Whole-cell protein extracts from the WT pro- and pre-B cells
were prepared as mentioned previously.40 Fifty micrograms of
total protein was analyzed in an 8% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and subjected to
immunoblotting for detection of calcineurin (Cell Signaling
Technology) and PLCγ2 (Santa Cruz) levels. Actin was used as a
loading control.
In vitro kinase assays
Rag1−/− pro-B cells (107) were lysed in modified RIPA buffer, and the
cell lysates were incubated with 5 μg JAK3 Ab (Santa Cruz Biotech)
overnight (o/n) at 4 °C to immunoprecipitate JAK3. Subsequently, 20
μl protein A agarose beads were added to the cell lysate and
incubated for 1 h at 4 °C to capture the immunoprecipitated JAK3.
The beads were washed one time in 1× tyrosine kinase buffer (60
mM HEPES, 5mM MgCl2, 5mM MnCl2, 3 μM Na3VO4, and 2.5 μM
DTT), and kinase reactions were set up by adding 10 μg of
glutathione S-transferase (GST)-NFATc1 or GST-STAT5 (signal trans-
ducer and activator of transcription factor 5) protein with 20 μM ATP
and 10 μCi γATP in radioactive assays at 22 °C for 30min. For the
non-radioactive assays, kinase reactions were performed without
addition of γATP to the reaction mixture. Samples were analyzed by
6–8% SDS-PAGE followed by autoradiography for γ-32P incorpora-
tion or immunoblotted to detect phospho-tyrosine.
V-D-J recombination
For analysis of rearranged Ig heavy and light chain genes, cDNA
was synthesized from sorted B220+CD43+ pro-B cells from WT and
Vav-CreNfatc1fl/fl mice using the Miltenyi Biotec cDNA Synthesis Kit
and protocol. Semiquantitative reverse transcriptase–polymerase
chain reaction (RT-PCR) was performed to measure the expression
of various rearranged heavy and light chain genes as well as germ
line transcripts, using previously described primer pairs.41
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts (NEs) prepared from freshly isolated BM B220+ B
cells from Rag1−/− mice were analyzed in EMSA for DNA binding
of NFATc1 at the Ebf1 promoter. The following oligonucleotides
were used as EMSA probes: Ebf1 I: 5′-ATCTACACGCACGGAAAG
GAAAGAAACATCTTTGGTT-3′, Ebf1 II: 5′-TGAGAGAGGAGGAGGA
AAAAAGAGAGAGAAAAAAACT-3′, and Ebf1 III: 5′-CTTGCCTGGTTGT
GGAAAATGACACTTCAAGT-3′, representing conserved NFAT sites I,
II, and III at the Ebf1 promoter. An oligonucleotide containing the
distal NFAT site at the murine Il2 promoter (Il2Pu-bd) was used as a
positive control: (–292) 5′-CCAAAGAGGAAAATTTGTTTCATACA-
GAAGGC-3′ (–261). Five micrograms of nuclear proteins was
incubated with 1 μg poly-dI.dC and 1 μl γ-32P-labeled Il2Pu-bd or
Ebf1 probes for 20min on ice. For competition, a 100-fold molar
excess of unlabeled cold probe was used, and in the supershift
assays, 3 μg NFATc1, NFATc2, or NFATc3 Abs were used to
evaluate the specificity of the NFAT–DNA complexes. DNA-bound
NFAT complexes were resolved in 5% non-denaturing gels using
0.5× TBE buffer at 140 V for 2 h. Subsequently, the gels were
transferred to Whatman filter papers and vacuum-dried for 2 h.
Dried gels were exposed to photographic film o/n at −20 °C, and
NFAT–DNA complexes were visualized in the autoradiogram. Free
probe: labeled oligos without NE, in each probe set, lane 1:
NFAT–DNA complexes, lane 2: competition with cold oligos, lane
3: supershift with NFATc1 Abs, lane 4: supershift with NFATc2 Abs,
and lane 5: supershift with NFATc3 Abs.
Chromatin immunoprecipitation (ChIP)
For each ChIP assay, 5–8 × 106 WT pro-B cells were used following
the Miltenyi Biotech ChIP protocol. Eight micrograms of NFATc1
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(Santa Cruz Biotech; sc-7294) or GST (A-6; Santa Cruz Biotech) Abs
were used for immunoprecipitation o/n at 4 °C. Protein-DNA
complexes were precipitated, and DNA fragments bound to
NFATc1 or GST were purified. The purified DNA fragments were
used in PCR assays to amplify the Ebf1 promoter region bound to
NFATc1 or GST. Primer sequences used to detect the Ebf1
promoter region are available in Supplementary Table 1.
Luciferase reporter assays
Murine Ebf1a or Ebf1b luciferase reporter constructs (100 ng)42
were co-transfected independently along with 1000 ng control
vectors, expression vectors for a constitutively active STAT5
(STAT5ca) or NFATc1 (Nc1) alone, or with both STAT5 and NFATc1
together into 293 HEK cells using TurboFect Transfection Reagent
(Thermo Scientific™, # R0531). At 24 h post-transfection, the cells
were left unstimulated or stimulated with 12-O-tetradecanoyl-
phorbol-13-acetate plus ionomycin (100 ng/ml each, Calbiochem)
in the absence or presence of cyclosporin A (CsA, 100 ng/ml) for
16 h. Subsequently, luciferase activity depicting Ebf1a and Ebf1b
promoter transactivation was measured using a MicroLumat LB
96P (EG&G Berthold) luminometer.
Photographs
Photographs of the thymus, spleen, and lymph nodes (LNs) from
WT, Vav-CreNfatc1fl/+, and Vav-CreNfatc1fl/fl mice or the spleen
and LNs from WT and Vav-CreNfatc1P2fl/fl mice were obtained
using a Nikon Coolpix 4500 digital camera. Image processing was
performed using the Adobe Photoshop software.
Fig. 1 NFAT Expression in pro-B cells. a Immunofluorescence revealing the expression of NFATc1, NFATc2, and NFATc3 in WT B220+CD43+ pro-
B and B220+CD43− pre-B cells. b Quantification of the nuclear NFATc1 (pro-B; n= 32 and pre-B; n= 81), NFATc2 (pro-B; n= 38 and pre-B; n=
64), and NFATc3 (pro-B; n= 13 and pre-B; n= 32) levels in WT pro- and pre-B cells. c NFATc1 expression levels in Rag1−/− pro- and pre-B cells.
d Quantification of the nuclear NFATc1 (pro-B; n= 14 and pre-B; n= 28) levels in Rag1−/− pro- and pre-B cells. e Flow cytometry profiles
showing the distribution of CD3+ T cells and B220+ B cells in the BM and spleen of Nfatc2−/−, Nfatc3−/−, and Nfatc2−/−Nfatc3−/− mice
compared with WT mice. f GFP levels in BM B220+CD19+IgM−c-Kit+ pro-B, B220+CD19+IgM−CD25+ pre-B, B220−CD19+IgM+IgD− immature
B, and B220+CD19+IgM+IgD+ mature B cells from Nfatc1-eGfp-Bac tg reporter mice compared with WT mice. g Levels of calcineurin and Plcg2
mRNA expression in sorted WT B220+CD43+ pro-B and B220+CD43− pre-B cells, as revealed by RT-PCR. h Immunoblot analysis of the protein
levels of calcineurin and PLCg2 in sorted WT B220+CD43+ pro-B and B220+CD43− pre-B cells. i IL-7R expression in WT pro- and pre-B cells. j In
vitro kinase assays revealing JAK3-mediated phosphorylation of NFATc1 and STAT5. k Kinase assay followed by immunoblotting revealing
JAK3-mediated tyrosine phosphorylation in NFATc1. Data are representative of three independent experiments (n= 3–7 per group) and are
shown as the mean ± s.d., unpaired t test (b, d)
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Semiquantitative RT-PCR
Sorted B220+CD43+ pro- and B220+CD43− pre-B cells from WT
mice, pro-B cells from WT, Vav-CreNfatc1fl/+ and Vav-CreNfatc1fl/fl
mice, sorted WT double-negative 3 (DN3) thymocytes, and Vav-
CreNfatc1P2fl/fl mouse thymocytes and pro-B cells were used to
synthesize cDNA using the Miltenyi Biotec cDNA Synthesis Kit and
protocol. Semiquantitative RT-PCR was performed to estimate the
expression levels of the indicated genes. Primer sequences are
available in the supplementary information online.
Statistics
Data are presented as the mean ± s.d. Statistical significance was
assessed using Student’s t test for comparison between two
groups and analysis of variance for differences among groups.
RESULTS
NFAT activation in pro-B cells
To investigate whether TFs of the NFAT family play any role in B
cell development in BM, we analyzed WT pro- and pre-B cells for
the presence of NFAT proteins. Immunofluorescence analysis of
WT B220+CD43+IgM− pro-B cells revealed many fold higher
nuclear NFAT levels compared with B220+CD43−IgM+ pre-B cells
(Fig. 1a, b). Confirming this finding, analysis of pro-B (B220+IL-7R+)
and pre-B (B220+IL-7R−) cells isolated based on IL-7R expression
revealed a similar NFAT distribution pattern (Supplementary
Figure S1a and b). Irrespective of the markers used to identify
pro- and pre-B cells, NFAT activation in pBCR-negative pro-B cells
was higher for NFATc1, NFATc2, and NFATc3 compared with that
in pBCR-positive pre-B cells (Fig. 1a, b and Supplementary
Figure S1a and b). This observation was further consolidated by
analyses of Rag1−/− pro-B cells. Similar to WT pro-B cells, Rag1−/−
pro-B cells also exhibited high levels of nuclear NFATc1 (Fig. 1c, d),
suggesting that NFAT proteins most likely play a role at the
preBCR-negative stages of B cell development in BM.
Owing to the high levels of NFATc1, NFATc2, and NFATc3 in pro-B
cells, we next investigated which of the three NFAT family members
is critical for early B cell development. Analysis of the B cell
population in the BM of Nfatc2−/− or Nfatc3−/− mice revealed
comparable proportions of B220+ cells as in WT mice (Fig. 1e). Even
the combined loss of both NFATc2 and NFATc3 (Nfatc2−/−Nfatc3−/−)
did not alter B220+ population in BM (Fig. 1e), suggesting that
NFATc2 and NFATc3 activity was most likely dispensable and that
NFATc1 was the key NFAT protein regulating early B cell
differentiation. This observation was supported by an earlier report
that did not reveal any abnormality in early B cell development in
Nfatc2−/−, Nfatc3−/−, or the double-mutant mice, although mature
splenic B cell function was affected.36 NFATc1 expression in early B
cell developmental stages was further confirmed, as
B220+CD19+IgM−c-Kit+ pro-B cells from Nfatc1-eGfp-Bac transgenic
(tg) reporter mice34,37,43 showed high GFP levels compared with
those from WT mice (Fig. 1f and Supplementary Figure S1c). In fact,
varying levels of GFP representing NFATc1 expression in pro-B,
B220+CD19+IgM−CD25+ pre-B, B220+CD19+IgM+IgD− immature B,
and B220+CD19+IgM+IgD+ mature B cells in BM (Fig. 1f and
Supplementary Figure S1c) and in splenic B cells (Supplementary
Figure S1d) suggest that NFATc1 activity plays an essential role in B
cell development and function.
To gain insight into how NFAT is activated in pro-B cells, we
analyzed the expression of components of the classical NFAT
activation pathway, i.e., the PLCγ2–calcium–calcineurin pathway.
RT-PCR as well as immunoblot analysis showed that, compared
with pre-B cells, pro-B cells expressed very low levels of Plcg2 and
calcineurin (Pp2b) (Fig. 1g, h). Considering the high levels of NFAT
(Fig. 1a–d and Supplementary Figure S1a and b) and insignificant
expression of Plcg2 and calcineurin, it was apparent that NFAT
activation was calcineurin independent in pro-B cells. This finding
was supported by observations from previous reports showing
normal early B cell development in the BM of calcineurin-deficient
mice.44,45
To understand the mechanism of NFAT activation, we
investigated whether IL-7-JAK3 signaling also activates NFATc1
in pro-B cells as we have observed in thymocytes.33 Pro-B cells
depend on IL-7 signaling for survival and differentiation.46,47
Accordingly, we detected high levels of IL-7R expression on pro-B
compared with pre-B cells (Fig. 1i). To characterize the involve-
ment of JAK3, we performed kinase assays with JAK3 immuno-
precipitated from pro-B cells. In kinase assays, JAK3
phosphorylated NFATc1 as well as STAT5, indicating that, similar
to observations in thymocytes, JAK3 plays the role of NFAT kinase,
resulting in NFAT activation and nuclear translocation in pro-B
cells (Fig. 1j). JAK3-mediated tyrosine phosphorylation of
NFATc1 was confirmed by immunoblotting the kinase assay
products with pTyr Abs (Fig. 1k). These observations suggest that
NFAT activation in pro-B cells is dependent on IL-7-JAK3 signaling.
Impaired B cell development in the absence of NFATc1
NFATc1-deficient mice are embryonic lethal.48 To circumvent this
problem and investigate the influence of NFATc1 on early B cell
developmental stages, we analyzed Vav-CreNfatc1fl/fl mice, in
which NFATc1 activity was ablated in the hematopoietic system.
Analysis of Vav-CreNfatc1fl/fl mice showed a consistent and strong
reduction in the size of primary lymphoid organs, such as the
thymus, LNs, and spleen (Fig. 2a). A reduction of the thymus size in
Vav-CreNfatc1fl/fl mice due to developmental defects in thymocyte
differentiation has been reported.33 The small LNs and spleen in
Vav-CreNfatc1fl/fl mice suggest possible defects in B cell develop-
ment, as B cells constitute a major cell population in these organs.
Accordingly, spleen cellularity was drastically reduced in Vav-
CreNfatc1fl/fl mice compared with their littermate controls (Fig. 2b).
Analysis of T and B cell distributions in the spleen revealed a
strongly reduced B220+ B cell population in Vav-CreNfatc1fl/fl mice
(Fig. 2c, d). Further assessment of IgM and IgD-expressing B cells in
the spleen confirmed that the loss of NFATc1 activity exerted a
strong negative influence on B cell development (Fig. 2e, f).
In the absence of NFATc1 activity, very few CD21+CD23+
follicular and CD21+CD23− marginal zone B cells, as well as
B220+CD5+ B-1 B cells, developed in Vav-CreNfatc1fl/fl mice
(Fig. 2g–n). Additionally, IgM+ B cells in the peritoneum were
markedly reduced in Vav-CreNfatc1fl/flmice compared with WT
control mice (Fig. 2k, l). This strong phenotype in the absence of
NFATc1 activity further confirmed that NFATc1 is the key NFAT
protein essential for B cell development, and NFATc2 or NFATc3
cannot compensate for its loss. The reduced B220+CD5+
population in Vav-CreNfatc1fl/fl mice is in agreement with previous
reports concerning the requirement for NFATc1 for the develop-
ment of these cells.35 Taken together, these abnormalities in B cell
populations in the peripheral lymphoid organs of Vav-CreNfatc1fl/fl
mice indicate a defect in B lymphopoiesis in the BM.
B cell development in BM is critically dependent on NFATc1
activity
To elucidate the precise stage at which B cell development is
affected owing to the absence of NFATc1 activity, we analyzed B
cell differentiation in the BM of Vav-CreNfatc1fl/fl mice. BM
cellularity as well as BM B220+ B cell numbers were dramatically
reduced in Vav-CreNfatc1fl/fl mice, although an increase in the
percentage of distributed B220+ cells was observed (Fig. 3a, b).
Further analysis revealed a strong reduction in both the
percentage of distribution and in the absolute numbers of the
BM B220+CD43+ pro-B cells (Fig. 3c, d), as well as an increase in
the percentage but a marked reduction in the absolute numbers
of B220+CD43− pre-B cells (Fig. 3c, e) in Vav-CreNfatc1fl/fl
compared with WT mice. The B220+CD43+ population can be
further subdivided into three subsets based on the surface
expression of heat-stable antigen (CD24) and BP1 molecules, i.e.,
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B220+CD43+CD24−BP1− pre-pro-B cells, B220+CD43+CD24+BP1−
pro-B cells, and B220+CD43+CD24+BP1+ large pre-B cells.49 Our
analysis revealed that, in Vav-CreNfatc1fl/fl mice, B cell develop-
ment was arrested at the B220+CD43+CD24−BP1− pre-pro-B cell
stage (Fig. 3f, g). Very few cells differentiated to the later stages,
resulting in a dramatically reduced B cell population in the BM and
peripheral lymphoid organs (Figs. 3b and 2d). Similar to the
B220+CD43+ population, the B220+CD43− population can be
divided into three subsets based on the expression of IgM
and IgD molecules: B220+CD43−IgM−IgD− small pre-B,
B cell development is critically dependent on NFATc1...
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B220+CD43−IgM+IgD− immature B, and B220+CD43−IgM+IgD+
mature B cells.49 In Vav-CreNfatc1fl/fl compared with their
littermate control mice, there were very few B220+CD43−Ig-
M+IgD− immature and B220+CD43−IgM+IgD+ mature B cells,
confirming a developmental arrest at the pro-B cell stage due to
the absence of NFATc1 activity (Fig. 3h, i).
We have previously shown that the abolition of NFATc1 activity
in B cells (Mb1-CreNfatc1fl/fl mice) leads to defects in mature B cell
function, but it does not influence the early B cell differentiation
stages in BM.37 Correlating our observations with that from Mb1-
CreNfatc1fl/fl mice, it is apparent that NFATc1 activity at a stage
where the immature B cells still have not acquired the pBCR is
critical for B cell development. To investigate the basis behind the
differentiation block, we assumed that most likely lack of NFATc1
activity is impairing the IL-7 responsive stages of B cell
development in Vav-CreNfatc1fl/fl mice. Furthermore, analysis of
Il7r−/− and Il7−/− mice revealed a similar developmental arrest at
the early B cell differentiation stage, as observed in Vav-
CreNfatc1fl/fl mice (Fig. 3j and Supplementary Figure S2a). These
observations suggest that NFATc1 activation is indispensable for B
cell development in BM.
Loss of NFATc1 dysregulates Ebf1 and the expression of other B
lineage-specific genes
To gain insight into the defects in pro-B cell development in the
absence of NFATc1 activity, we analyzed the expression of various
molecules implicated to regulate B cell development. RT-PCR
analysis revealed NFATc1 was specifically and efficiently deleted in
pro-B cells of Vav-CreNfatc1fl/fl mice (Fig. 4a). However, normal
expression of NFATc2 and reduced expression of NFATc3 were not
sufficient to restore the B cell phenotype in Vav-CreNfatc1fl/fl mice,
ruling out any compensation by these NFAT family members
(Fig. 4a). Interestingly, analysis of molecules that are critically
involved in B lineage commitment and specification did not reveal
any alterations in the expression of Spi1 (PU.1), Tcf3 (E47), Tcf12
(HEB), Oct1, Oct2, Id1, Id2, and Id3, ruling out any involvement of
NFATc1 in the regulation of these genes (Fig. 4a). In fact, all these
genes were slightly upregulated in Vav-CreNfatc1fl/fl pro-B cells.
Several NF-κB family members have been shown to regulate B cell
development, as evidenced in studies examining gene-deficient
mice.50,51 However, we observed an elevated level of Rela (P65),
Relb, and Nfkb2 expression in Vav-CreNfatc1fl/fl compared with WT
mouse pro-B cells (Fig. 4a). Interestingly, we observed a strong
downregulation of Ebf1 expression as well as reduced expression
of Foxo1 and Pax5 in Vav-CreNfatc1fl/fl compared with WT mouse
pro-B cells (Fig. 4a). Reduced Pax5 expression could be due to a
downregulation of EBF1 activity, as it has been reported that Pax5
expression is regulated by EBF1.16 Thus EBF1 seems to be the
prime target of NFATc1 during pro-B cell development.
Based on our analysis, the B cell developmental defect in Vav-
CreNfatc1fl/fl mice clearly occurs at a similar stage as that in IL-7- or
IL-7R-deficient mice (Fig. 3j and Supplementary Figure S2a).3,4 To
exclude the possibility that the absence of NFATc1 activity impairs
IL-7-STAT5 signaling, we investigated the expression of all
components of the IL-7 signaling pathway. Normal expression of
Il7ra, Jak3, Stat5a, and Stat5b genes in Vav-CreNfatc1fl/fl compared
with WT mouse pro-B cells (Fig. 4b) excluded the possibility that
the absence of STAT5 activity was responsible for the arrested B
cell development in Vav-CreNfatc1fl/fl mice. The B cell develop-
mental arrest in IL-7- and IL-7R-deficient mice has been attributed
to the absence of EBF1 expression.24 The lack of EBF1 expression
in Vav-CreNfatc1fl/fl mice (Fig. 4a) resembles to that in IL-7 and IL-
7R-deficient mice and suggests that NFATc1 is an important
downstream target of IL-7 signaling.
In addition to the defect in Ebf1 expression, pro-B cells in Vav-
CreNfatc1fl/fl displayed a strong downregulation of the Rag1, Rag2,
and Tdt (Dntt) genes involved in the recombination and
rearrangement of Ig genes. Furthermore, Vav-CreNfatc1fl/fl pro-B
cells lacked expression of λ5 (Igll1), VpreB, Ig-α (Cd79a), and Ig-β
(Cd79b), all of which are components of the pBCR complex. These
observations suggest that NFATc1 is a critical player in B cell
development, and the absence of NFATc1 can have profound
effect on B lymphopoiesis. We also observed similar defects in
early-B cell differentiation-specific gene expression in IL-7 signal-
ing-deficient pro-B cells, which was in agreement with previously
published reports (Supplementary Figure S2b).
EBF1 expression in pro-B cells is regulated from two distinct
promoters, leading to the expression of EBF1α and EBF1β
isoforms.42 It has been reported that EBF1β is the major isoform
expressed in pro-B cells and regulates the expression of EBF1α. In
investigations to determine which EBF isoform was affected by the
absence of NFATc1, we observed that both Ebf1a and Ebf1b were
strongly downregulated in Vav-CreNfatc1fl/fl mouse pro-B cells
(Fig. 4c), suggesting that EBF1 is a target of NFATc1 in pro-B cells.
NFATc1 regulates EBF1 expression in pro-B cells
To investigate whether NFATc1 transcriptionally regulates EBF1
expression, we searched for the NFAT DNA-binding consensus
sequence 5′-GGAAA-3′ approximately 1 kb upstream of the Ebf1b
transcriptional start site. We detected five NFAT consensus
sequences in this upstream sequence, four of which were
conserved in mouse and human (Fig. 5a). To verify NFATc1
binding to these conserved sites, we performed EMSAs with NE
prepared from WT pro-B cells. As shown in Fig. 5b, NFATc1
binding was detected in sites I, II, and III, with the second and third
conserved sites showing a higher affinity in comparison to site I.
NFATc1 binding to site IV was weaker than to the other three
conserved sites (data not shown). NFATc1 binding to these sites
was abolished specifically by an Ab against NFATc1, whereas the
complex remained unaltered in the presence of Abs against either
NFATc2 or NFATc3 (Fig. 5b). Furthermore, strengthening our
observations regarding NFATc1-mediated regulation of Ebf1
expression, ChIP assays revealed the in vivo NFATc1 binding at
the Ebf1 promoter in WT pro-B cells (Fig. 5c). Supporting these
observations, in reporter assays, we observed minimal transacti-
vation of the Ebf1b promoter by NFATc1 (Fig. 5d). However,
Fig. 2 Impaired B cell development in Vav-CreNfatc1fl/fl mice. a Photographs of the thymus, spleen, and LNs from Vav-CreNfatc1fl/fl mice
compared with littermate Vav-CreNfatc1fl/+ and WT mice. b Total splenocyte numbers in WT (n= 8), Vav-CreNfatc1fl/+ (n= 8), and Vav-
CreNfatc1fl/fl (n= 9) mice. c Flow cytometry showing the distribution of CD3+ T and B220+ B cells in the spleen from Vav-CreNfatc1fl/fl mice
compared with WT controls. d Absolute numbers of B220+ B cells in the spleen from Vav-CreNfatc1fl/fl (n= 9) mice compared with littermate
control (n= 8 for both Vav-CreNfatc1fl/+ and WT) mice. e, f Distribution of IgM+ and IgD+ B cells in the spleen (e) and quantification of the %
cells (f) from WT and Vav-CreNfatc1fl/fl mice. g, h Follicular and marginal zone B cell distribution in the spleen (g) and quantification of the
percentage of cells (h) from Vav-CreNfatc1fl/fl mice compared with littermate control mice as revealed by CD21 and CD23 staining.
i, j Distribution of splenocytes according to CD5 and IgM expression (i) and quantification of the percentage of cells (j) in WT and Vav-
CreNfatc1fl/fl mice. k, l Distribution of CD5+ and IgM+ cells (k) and quantification of the percentage of cells (l) in the peritoneum of Vav-
CreNfatc1fl/fl mice compared with WT controls. m, n Distribution of follicular and marginal zone B cells (m) and quantification of the
percentage of cells (n) in the peritoneum of Vav-CreNfatc1fl/fl mice compared with WT controls. Numbers within each dot plot represent the
percentage of the respective population. Data represent one of the three independent experiments (n= 3 per group) and are shown as the
mean ± s.d., one-way ANOVA (b, d), and unpaired t-test (f, h, j, l, n)
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NFATc1 in combination with STAT5 increased Ebf1b promoter
activity by several fold, and this effect was reduced when NFATc1
activity was blocked by CsA treatment (Fig. 5d). Interestingly,
NFATc1 exerted a similar influence on the Ebf1a promoter,
suggesting that both Ebf1a and Ebf1b are transcriptionally
regulated by NFATc1 (Fig. 5d), which supports our observations
of strongly reduced expression of both isoforms in Vav-CreNfatc1fl/fl
pro-B cells (Fig. 4c). These observations suggest that, down-
stream of IL-7 signals, NFATc1 and STAT5 synergistically
regulate Ebf1 activity and critically influence early B cell differentia-
tion in BM.
NFATc1 regulates Ig gene rearrangement in pro-B cells
As B cell development in Vav-CreNfatc1fl/fl mice was arrested at
the pro-B cell stage, we analyzed the rearrangement status of the
IgH and IgL chain locus. RT-PCR analysis revealed that, compared
with WT pro-B cells, transcripts for either κ- or λ-light chains as
well as the proximal and distal VH segment containing the IgH
chain were negligible in Vav-CreNfatc1fl/fl pro-B cells (Fig. 6).
Correspondingly, germline transcripts for distal VH segments were
absent in Vav-CreNfatc1fl/fl pro-B cells, indicating a defect in Ig
heavy chain locus accessibility (Fig. 6) and raising the possibility of
NFATc1 acting as a facilitator of Ig gene locus accessibility and
Fig. 3 Lack of NFATc1 activity arrests pro-B cell differentiation to pre-B cells. a Cellularity in the BM of WT and Vav-CreNfatc1fl/fl mice. b B220+ B
cell distribution both as a percentage of the population and as the absolute numbers in the BM of WT and Vav-CreNfatc1fl/fl mice. c Flow
cytometry profiles showing the distribution of BM cells based on B220 and CD43 expression in WT and Vav-CreNfatc1fl/fl mice.
d Quantification of the percentage of distribution and absolute numbers of B220+CD43+ pro-B cells in the BM of WT and Vav-CreNfatc1fl/fl
mice. e Quantification of the percentage of distribution and absolute numbers of B220+CD43− pre-B cells in the BM of WT and Vav-CreNfatc1fl/
fl mice. f, g B220+CD43+CD24−BP1− pre-pro-B, B220+CD43+CD24+BP1− pro-B, and B220+CD43+CD24+BP1+ large pre-B cell distributions in
the BM (f) and the quantification of their percentage of distribution (g) from Vav-CreNfatc1fl/fl mice compared with WT controls.
h, i B220+CD43−IgM−IgD− small pre-B, B220+CD43−IgM+IgD− immature B, and B220+CD43−IgM+IgD+ mature B cell distributions in BM
(h) and the quantification of their percentage of distribution (i) from WT and Vav-CreNfatc1fl/fl mice. j Distribution of B cells gated on the
B220+CD43− population in BM from Il7−/− and Il7r−/− mice based on IgM and IgD expression compared with littermate WT mice. Numbers
inside each dot plot represent the percentage of the respective population. Data represent one of three independent experiments (n= 3 per
group) and are shown as the mean ± s.d., unpaired t test
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rearrangement. This result further supports a role for NFATc1
downstream of IL-7 signaling in the regulation of B cell
developmental events, as IL-7 signaling has been reported to
regulate IgH locus accessibility.52,53
A threshold level of NFATc1 activity is essential for B cell
differentiation
NFATc1 is expressed from two distinct promoters. NFATc1α
isoforms are directed from the distal P1 and NFATc1β isoform
expression is directed from the proximal P2 promoter.54 We have
recently demonstrated distinct developmental stage-specific
Nfatc1 promoter activity during thymocyte differentiation with
NFATc1β isoforms expressed in pTCR-negative cells and both
NFATc1α and NFATc1β activity in pTCR-positive thymocytes.34 To
assess whether a similar pattern of NFATc1 promoter activity
occurs during B cell development, we evaluated Nfatc1a and
Nfatc1b-specific transcripts in WT pro- and pre-B cells. We
observed strong P2 promoter-derived NFATc1β expression in
B220+CD43+ pro-B cells, whereas pBCR-positive B220+CD43− pre-
B cells showed strong expression of both NFATc1β and P1
promoter-derived NFATc1α (Fig. 7a). Thus NFATc1β isoforms
probably play a critical role in the differentiation of pro-B cells
in the absence of pBCR signaling, and pBCR-bearing B cells require
both NFATc1β and NFATc1α for further differentiation into mature
B cells.
To further investigate whether exclusive NFATc1β activity is
really critical, and whether B cell differentiation is impaired in the
absence of P2 promoter activity, we analyzed Vav-CreNfatc1P2fl/fl
mice.34 However, preliminary analysis of the LNs, spleen, and BM
in these mice did not reveal any perturbations in size or cellularity,
suggesting that B cell differentiation was normal in the absence of
P2-derived NFATc1β (Fig. 7b, c). Further characterization revealed
a normal distribution of B220+ B cells in the BM and spleen of
these mice (Fig. 7d and Supplementary Figure S3a). Additionally,
the unaffected distribution of B220+IgM+ and B220+IgD+ B cells
and of the follicular (CD21+CD23+) and marginal zone
(CD21+CD23−) B cells in the spleen of Vav-CreP2fl/fl mice revealed
that B cell development was comparable to that in WT mice
(Fig. 7e and Supplementary Figure S3b). These observations are in
stark contrast to the arrested B cell development in Vav-
CreNfatc1fl/fl mice, which led us to investigate whether NFATc1
activity was still present in pro-B cells in Vav-CreNfatc1P2fl/fl mice.
RT-PCR analysis revealed a complete loss of P2 promoter activity,
but surprisingly, in the absence of Nfatc1b, robust expression of
Nfatc1a directed from the P1 promoter was observed in Vav-
CreNfatc1P2fl/fl mice (Fig. 7f). Thus the normal B cell development
Fig. 4 Abnormal B cell development-specific gene expression in Vav-CreNfatc1fl/fl pro-B cells. a RT-PCR analysis of gene expression, including
transcription factors that regulate B cell development, molecules associated with V-D-J recombination, pBCR components, and other signaling
molecules, in Vav-CreNfatc1fl/fl pro-B cells compared with littermate control mice. b Il7r, Jak3, Stat5a, and Stat5b gene expression in pro-B cells
from the indicated mice. c Levels of Ebf1a and Ebf1b isoform expression in Vav-CreNfatc1fl/fl mice compared with littermate control mice. Data
are representative of two independent experiments with cDNA prepared from sorted cells collected from pooled BM cells from multiple mice
for each genotype in each experiment
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in Vav-CreNfatc1P2fl/fl mice was clearly due to compensation for
the lost NFATc1β activity by the NFATc1α isoforms. These
observations further underline the importance of NFATc1 in B
cell development.
To gain insight concerning the absence of NFATc1α expression
at the pro-B cell stage, when it is present in pre-B cells along with
NFATc1β (Fig. 7a) and is able to replace NFATc1β activity during
early B cell development (Fig. 7f), we analyzed Vav-CreNfatc1αAfl/fl
mice in which a constitutively active version of Nfatc1αA was
knocked-in in the Rosa-26 locus flanked by a floxed stop
cassette.34 Surprisingly, analysis of the spleen and BM revealed
an NFATc1αA dose-dependent decrease in cellularity, suggesting
a possible defect in B cell development in Vav-CreNfatc1αAfl/fl
mice (Fig. 7g). Characterization of the B cell populations revealed a
drastic reduction of B220+ cells in the BM and spleen (Fig. 7h and
Supplementary Figure S4a). Furthermore, we observed a severe
lack of IgM+ and IgD+ B cells in the BM and spleen, as well as
follicular and marginal zone B cells in the spleen of Vav-
CreNfatc1αAfl/fl mice compared with their littermate controls
(Fig. 7i, j and Supplementary Figure S4b and c). Additionally, the
development of B220+CD19+CD5+ B cells in the spleen was also
Fig. 5 NFATc1 binds the Ebf1 promoter and regulates its activity. a Conserved NFAT-binding consensus sequence (5′-GGAAA-3′) in the Ebf1b
promoter region 1-kb upstream of the transcriptional start site in mice and humans. b Electrophoretic mobility shift assay (EMSA) with nuclear
extracts from BM pro-B cells showing NFATc1 binding at the conserved NFAT consensus sites in the Ebf1 promoter region. Ebf1 I, Ebf1 II, and
Ebf1 III indicate the oligos used in EMSA containing the first, second, and third NFAT-binding sites. In each set, lane 1 represents NFAT–DNA
complexes; lane 2, competition with 100-fold excess corresponding cold oligos; lane 3, supershift of NFAT–DNA complexes with NFATc1 Abs;
lane 4, supershift of NFAT–DNA complexes with NFATc2 Abs; and lane 5, supershift of NFAT–DNA complexes with NFATc3 Abs. In the case of
Il2Pu box-distal (Il2Pu-bd), lanes 1–3 represent NFAT–DNA complexes, cold oligo competition, and supershift with NFATc1 Abs, respectively. c In
vivo NFATc1 binding at the Ebf1 promoter as revealed in the ChIP assays. d Transactivation of Ebf1a and Ebf1b promoters in response to
NFATc1 or STAT5 activity alone or both together as revealed by luciferase reporter assays. Data are representative of three independent
experiments and are shown as the mean ± s.d., one-way ANOVA (d)
Fig. 6 NFATc1 deficiency impairs V-D-J recombination in Vav-
CreNfatc1fl/fl pro-B cells. RT-PCR analysis showing V-J and V-D-J
recombination at the light and heavy chain locus, respectively, in
pro-B cells from Vav-CreNfatc1fl/fl mice compared with littermate
control mice. Data are representative of two independent experi-
ments with cDNA prepared from sorted cells collected from pooled
BM cells from multiple mice for each genotype in each experiment
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severely affected in Vav-CreNfatc1αAfl/fl mice (Fig. 7k and
Supplementary Figure S4d). To locate the precise stage at which
B cell development was arrested as a result of NFATc1αA co-
expression along with NFATc1β, we analyzed the distribution of
B220+CD19+IgM−CD25+ pre-B cells in the BM of Vav-
CreNfatc1αAfl/fl mice. A drastically reduced pre-B cell population
in the BM revealed that, similar to the Vav-CreNfatc1fl/fl mice, B cell
development in Vav-CreNfatc1αAfl/fl mice was blocked at the pro-B
cell stage (Fig. 7l and Supplementary Figure S4e). These
observations suggest that NFATc1α activity in addition to
B cell development is critically dependent on NFATc1...
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NFATc1β activity at the pro-B cell stage is detrimental for B cell
development, and a certain threshold of NFATc1 activity
irrespective of the α or β isoforms is indispensable for normal B
cell differentiation.
DISCUSSION
The role of NFAT proteins in early B cell developmental stages,
during which they do not even have a pBCR, is not known. Our
findings concerning NFAT protein expression in pro-B cells are
quite intriguing (Fig. 1a–d and Supplementary Figure S1a and b). A
previous report investigating the role of NFATc2 and NFATc3 in B
cell development did not observe any abnormality in the BM,
although the function of mature B cells was affected.36 This
phenomenon could be due to a functional compensation by
NFATc1 in the absence of NFATc2 and NFATc3. Nfatc1−/− mice are
embryonic lethal.48 Therefore, in an attempt to define the role of
NFATc1 in B cells, we have previously used conditional mutant
mice in which NFATc1 activity is ablated in a B cell-specific manner
using Cd79a (Mb1, Iga)-Cre transgenic mice (Mb1-CreNfatc1fl/fl).37
Although Igα is a component of the pBCR and is involved in pBCR
signaling, analysis of Mb1-CreNfatc1fl/fl mice did not reveal any
defects in early B cell development.37 However, functional defects
in mature B cells were observed. These findings suggested that
the absence of NFATc1 activity at a stage when B cells have
already acquired the pBCR might not be appropriate to unravel its
role in pBCR-negative stages of differentiation. Accordingly, Vav-
Cre-mediated ablation of NFATc1 activity demonstrated the
critical role played by NFATc1 in pro-B cell differentiation, which
was not compensated by NFATc2 or NFATc3 (Figs. 2 and 3). The
severe B cell lymphopenia observed in the absence of NFATc1
activity (Fig. 2c, d) was not present in mice that were deficient in
NFATc2, NFATc3, or both (Fig. 1e). These observations attribute a
specific role to NFATc1, in contrast to the other NFAT family
members, in regulating B cell development in the BM.
Applying multiple approaches, we demonstrated the expression
of NFATc1 in pBCR-negative pro-B cells (Fig. 1a–d, f Supplemen-
tary Figure S1a and b, and Fig. 7a). The functional significance of
NFATc1 in these cells was clearly demonstrated by the B cell
lymphopenia observed in Vav-CreNfatc1fl/fl mice (Fig. 2c, d). In
contrast to pBCR- or BCR-bearing B cells, pBCR-negative pro-B cells
employ the alternative IL-7-Jak3-mediated mode to activate
NFATc1,33 as evidenced in our kinase assays with immunopreci-
pitated JAK3 from pro-B cells (Fig. 1j, k). The role of NFATc1 in B-1
B cell development has been previously reported.35 Our analysis of
NFATc1 ablation at the earliest stages provides evidence that it is
indispensable for the development of all types of B cells (Figs. 2
and 3).
The block at the pro-B cell stage in Vav-CreNfatc1fl/fl mice
(Fig. 3f, g) was similar to that previously reported in Il7−/− and
Il7r−/− mice, suggesting that the interruption of IL-7-NFATc1
signaling might be the cause of this phenotype. EBF1 deficiency
has been reported to be the main factor underlying the
developmental arrest at the pro-B cell stage in Il7−/− and Il7r−/−
mice.47 Regulation of Ebf1 expression by IL-7 signaling has also
been reported.16 However, the molecular mechanism linking IL-7
and Ebf1 expression is far from clear. Our observations regarding a
strong defect in Ebf1 expression in pro-B cells from Vav-
CreNfatc1fl/fl mice (Fig. 4a) suggested that, similar to Il7−/− and
Il7r−/− mice, the loss of EBF1 activity could be the major factor
responsible for the impaired B cell phenotype in these mice.
Although we also observed downregulated Pax5 expression
(Fig. 4a), it is not likely to be the reason for the observed
phenotype because EBF1 has been shown to regulate Pax5
expression.16 Moreover, the strong downregulation in pBCR
component expression (Cd79a, Cd79b, Vpreb, Igll1) and absence
of Rag1, Rag2, and Tdt expression in Vav-CreNfatc1fl/fl mice (Fig. 4a)
resembled the phenotype of EBF1-deficient mice, in which B cell
development is also arrested at the pro-B cell stage.12 Interest-
ingly, we observed an increase in the expression of Oct1, Oct2,
Rela, Relb, Nfakb2, and Spi1 in Vav-CreNfatc1fl/fl compared with
littermate control mice (Fig. 4a); however, increased expression of
these genes failed to rescue the B cell defects in Vav-CreNfatc1fl/fl
mice. Additionally, the higher levels of Tcf12, Tcf3, and Id protein
(Id1, Id2, and Id3) expression in Vav-CreNfatc1fl/fl pro-B cells had no
beneficial influence on B cell development (Fig. 4a). Overall, the
gene expression defects in Vav-CreNfatc1fl/fl pro-B cells were
similar to those observed in IL-7 signaling-deficient mice
(Supplementary Figure S2b). Most interestingly, despite the block
at the pro-B stage and the elevated expression levels of Notch
proteins (Fig. 4a), no increases in T lineage cells were observed in
Vav-CreNfatc1fl/fl mice. Our analysis clearly demonstrates that the
dysregulated Ebf1 expression in Vav-CreNfatc1fl/fl pro-B cells is the
result of a lack of NFATc1 activity (Fig. 5). The defect in V-D-J
recombination in Vav-CreNfatc1fl/fl pro-B cells (Fig. 6) again was
similar to that reported in Il7−/−, Il7r−/−, and Ebf1−/− mice.16,55 IL-7
signaling and EBF1 have been shown to regulate Ig gene
rearrangement.16,52,53 Again, the similarity in this aspect suggests
that IL-7, NFATc1, and EBF1 all act in a linear axis (Supplementary
Figure S5a) and that a deficiency in any one will lead to similar
defects in B cell development.
In pro-B cells, Nfatc1 expression occurred exclusively from the
P2 promoter, whereas in pre-B cells we could detect Nfatc1
expression from both the P1 and P2 promoters (Fig. 7a), marking a
qualitative and quantitative difference in NFATc1 proteins in pro-
and pre-B cells. This finding is again similar to our results obtained
for pTCR-negative and pTCR-positive thymocytes during T cell
development.33 In addition, this differential promoter-directed
NFATc1 expression in pro- and pre-B cells reflects the threshold of
NFATc1 activity required for their differentiation, as evidenced in
our analysis of Vav-CreNfatc1P2fl/fl mice, where in the absence of
P2, P1 promoter activity compensated for the loss of NFATc1β and
Fig. 7 Threshold level of NFATc1 activity is critical for B cell development. a Expression levels of Nfatc1a and Nfatc1b transcripts in
B220+CD43+ pro-B and B220+CD43− pre-B cells from WTmice. b Photographs of the spleen and LNs from Vav-CreNfatc1P2fl/fl mice compared
with littermate control mice. c Cellularity in the spleen and BM from the indicated mice (n= 3 in each group). d CD3+ T and B220+ B cell
distribution in the spleen and BM from Vav-CreNfatc1P2fl/fl mice compared with WT control mice. e Splenic distribution of immature and
mature (IgM vs IgD staining) and follicular and marginal zone (CD21 vs CD23 staining) B cells in WT and Vav-CreNfatc1P2fl/fl mice as revealed
by flow cytometry. f Levels of Nfatc1a and Nfatc1b transcripts in WT DN3 (CD4−CD8−CD44−CD25+) thymocytes and thymocytes and sorted
pro-B cells from Vav-CreNfatc1P2fl/fl mice. g Cellularity in the spleen and BM from Vav-CreNfatc1αAfl/fl mice (n= 12) compared with littermate
Vav-CreNfatc1αAfl/+ (n= 10) and WT mice (n= 9). h Flow cytometric profiles of the T and B cell distribution in the spleen and BM from Vav-
CreNfatc1αAfl/fl mice compared with littermate control mice. i IgM+ and IgD+ B cell distribution in the spleen and BM of Vav-CreNfatc1αAfl/fl
and WT mice gated on the B220+CD19+ population. j Follicular and marginal zone B cell distribution in the spleen from the indicated mice
gated on the B220+CD19+ population. k Distribution of CD5+ and IgM+ cells among the B220+CD19+ population in the spleen from Vav-
CreNfatc1αAfl/fl and WT mice. l Flow cytometric profiles showing the distribution of B220+CD19+IgM−CD25+ pre-B cells and
B220+CD19+IgM+CD25− immature B cells in the BM from Vav-CreNfatc1αAfl/fl mice compared with littermate control mice. Data represent
one of the two (b) or three independent experiments (n= 3–7 per group) and are shown as the mean ± s.d., paired t test (c), ns not significant,
and one-way ANOVA (g)
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facilitated normal B cell development (Fig. 7d, e and Supplemen-
tary Figure S3). Additionally and stressing the importance of a
threshold level of NFATc1 activity during a stage-specific
differentiation of B cells, increased NFATc1 levels via the co-
expression of NFATc1α along with NFATc1β in pro-B cells led to
severe B cell lymphopenia (Fig. 7g–l and Supplementary
Figure S4).
In summary, our study underlines the essentiality of an optimal
level of NFATc1 activity for B cell development and for preventing
B cell lymphopenia (Supplementary Figure S5b). Our study also
raises the possibility of manipulating NFATc1 activity to provide
relief in clinical cases of B cell immunodeficiency.
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